A senior researcher who can't get an answer from a shutdown NIH about a proposed clinical trial on a neurodegenerative disease, a Nobel Prize-winning scientist who fears that a generation of innovators will be lost, and a young investigator wearied at the lab by endless funding cuts and frustrated at home by the halt to promising research into a genetic disorder that affects her daughter
Two longtime ASCB members, Randy Schekman of the University of California, Berkeley, and James Rothman of Yale University, have won the 2013 Nobel Prize in Physiology or Medicine for their discoveries of how molecules move through the cell in vesicles and fuse to target membranes in a process known as "trafficking."
ASCB member Pascale Cossart of the Institut Pasteur in Paris won the 2013 International Balzan Prize, worth 750,000 Swiss francs (roughly $800,000), for her work on the molecular biology of pathogenic bacteria and their interaction with host cells. Speaking for the Balzan Foundation, Peter Suter, honorary vice president of the Swiss Academy of Medical Sciences, said, "Her research has provided very significant insights into the mechanisms underlying infectious diseases and how they might be combatted."
Just hours before the government may close down, federal employees around the world are waiting to hear if they will have to go to work in the morning. The question of the day in government buildings is which employees will be declared "essential" or "nonessential." Essential employees must show up for work even if the government is closed.